Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Shares  >  Nasdaq  >  Spectrum Pharmaceuticals, Inc.    SPPI

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
08/27/2015 08/28/2015 08/31/2015 09/01/2015 09/02/2015 Date
7.49(c) 7.6(c) 7.27(c) 7.02(c) 6.62(c) Last
1 734 506 1 484 070 1 054 976 1 898 199 3 520 593 Volume
+2.32% +1.47% -4.34% -3.44% -5.70% Change
More quotes
Financials ($)
Sales 2015 143 M
EBIT 2015 -55,4 M
Net income 2015 -61,7 M
Debt 2015 -
Yield 2015 -
Sales 2016 128 M
EBIT 2016 -64,3 M
Net income 2016 -67,6 M
Debt 2016 -
Yield 2016 -
PER 2015 -
PER 2016
Capi. / Sales 2015 3,11x
Capi. / Sales 2016 3,49x
Capitalization 446 M
More Financials
Company
Spectrum Pharmaceuticals, Inc. engages in the development and manufacture of pharmaceutical products.The firm acquires, develops, and commercializes a pipeline of clinical and commercial products under the FUSILEV, FOLOTYN, ZEVALIN, MARQIBO, and BELEODAQ brands.It operates through the United States... 
Sector
Biotechnology & Medical Research
Calendar
09/09 | 01:45pmPresentation
More about the company
Surperformance© ratings of Spectrum Pharmaceuticals,
Trading Rating : Investor Rating :
More Ratings
Latest news on SPECTRUM PHARMACEUTICALS,
07:03a SPECTRUM PHARMACEUTICALS : to Present Corporate Update at the Rodman & Renshaw 1..
07:02a SPECTRUM PHARMACEUTICALS : to Present Corporate Update at the Rodman & Renshaw 1..
09/02 SPECTRUM PHARMACEUTICALS : Announces Publication of Pivotal EVOMELA™ (melp..
08/20 SPECTRUM PHARMACEUTICALS : Enters Agreement with FDA
08/17 SPECTRUM PHARMACEUTICALS : Announces Agreement with FDA on the Special Protocol ..
08/11 SPECTRUM PHARMACEUTICALS : Reports Second Quarter 2015 Financial Results
08/06 SPECTRUM PHARMACEUTICALS : Pharma reports 2Q loss
08/06 SPECTRUM PHARMACEUTICALS : Results of Operations and Financial Condition, Financ..
More news
Sector news : Biotechnology & Medical Research - NEC
08:01a QUINTILES TRANSNATIONAL : CEO to Present at Morgan Stanley Global Healthcare Con..
07:37a QIAGEN NV : kit isolates high-quality RNA from exosomes in liquid biopsies
07:01a ISIS PHARMACEUTICALS : to Present at Upcoming Investor Conferences
More sector news : Biotechnology & Medical Research - NEC
News from SeekingAlpha
08/17 Spectrum Pharma reaches agreement with FDA on protocol of Phase 3 study of ap..
08/15 Most Shorted Stocks Getting Creamed
08/07 After Hours Gainers / Losers
08/06 Spectrum Pharmaceuticals' (SPPI) CEO Rajesh Shrotriya on Q2 2015 Results - Ea..
07/26 WEEK IN REVIEW : 3SBio Acquires Wansheng Pharma For $85 Million


Comments 
Advertisement
Chart SPECTRUM PHARMACEUTICALS,
Duration : Period :
Spectrum Pharmaceuticals,  Technical Analysis Chart | SPPI | US84763A1088 | 4-Traders
Full-screen chart
Technical analysis trends SPECTRUM PHARMACE...
Short TermMid-TermLong Term
TrendsBearishBullishNeutral
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions